Cathelicidin Insufficiency in Patients with Fatal Leptospirosis

PLoS Pathogens

Volumn 12, Issue 11, 2016, Pages

  Lindow, Janet C ^a,b   Wunder, Elsio A ^a,b   Popper, Stephen J ^c   Min, Jin Na ^d   Mannam, Praveen ^d   Srivastava, Anup ^d,f   Yao, Yi ^d,g   Hacker, Kathryn P ^a   Raddassi, Khadir ^d   Lee, Patty J ^d   Montgomery, Ruth R ^d   Shaw, Albert C ^d   Hagan, Jose E ^a,b   Araújo, Guilherme C ^b   Nery, Nivison ^b   Relman, David A ^c,i   Kim, Charles C ^e,h   Reis, Mitermayer G ^b   Ko, Albert I ^a,b  

^a YALE UNIVERSITY   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^g HENRY FORD HEALTH SYSTEM   (United States)

^h VERILY LIFE SCIENCES   (United States)

ⁱ VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; ELASTASE; INTERLEUKIN 18; INTERLEUKIN 37; RANTES; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN;

ACUTE LUNG INJURY; ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BACTEREMIA; BACTERIAL LOAD; BLOOD CLOTTING DISORDER; CASE FATALITY RATE; CHEMOTAXIS ASSAY; CHILD; CLINICAL ARTICLE; CONVALESCENCE; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; FLOW CYTOMETRY; GENE CLUSTER; GENETIC TRANSCRIPTION; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; INNATE IMMUNITY; JAUNDICE; LEPTOSPIROSIS; MALE; MORBIDITY; NONHUMAN; NORMAL HUMAN; OLIGURIA; PROTEIN EXPRESSION; SCHOOL CHILD; SERUM BACTERICIDAL ANTIBODY ASSAY; ANIMAL; BRAZIL; CLUSTER ANALYSIS; DISEASE MODEL; DNA MICROARRAY; HAMSTER; IMMUNOLOGY; MESOCRICETUS; METABOLISM; RISK FACTOR;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BRAZIL; CLUSTER ANALYSIS; CRICETINAE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; LEPTOSPIROSIS; MESOCRICETUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RISK FACTORS;

EID: 85001996829     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005943     Document Type: Article

References (73)

1. Ko AI, Goarant C, Picardeau M, Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nature reviews Microbiology. 2009;7(10):736–47. PubMed Central PMCID: PMC3384523. doi: 10.1038/nrmicro220819756012
2. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, et al. Control of neglected tropical diseases. N Engl J Med. 2007;357(10):1018–27. Epub 2007/09/07. doi: 10.1056/NEJMra06414217804846
3. Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS neglected tropical diseases. 2015;9(9):e0003898. PubMed Central PMCID: PMC4574773. doi: 10.1371/journal.pntd.000389826379143
4. Torgerson PR, Hagan JE, Costa F, Calcagno J, Kane M, Martinez-Silveira MS, et al. Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years. PLoS neglected tropical diseases. 2015;9(10):e0004122. PubMed Central PMCID: PMC4591975. doi: 10.1371/journal.pntd.000412226431366
5. Leptospirosis case notification records, Brazil. Health Surveillance Secretary Brazilian Ministry of Health; 2007.
6. Felzemburgh RD, Ribeiro GS, Costa F, Reis RB, Hagan JE, Melendez AX, et al. Prospective study of leptospirosis transmission in an urban slum community: role of poor environment in repeated exposures to the Leptospira agent. PLoS neglected tropical diseases. 2014;8(5):e2927. PubMed Central PMCID: PMC4038618. doi: 10.1371/journal.pntd.000292724875389
7. Gouveia EL, Metcalfe J, de Carvalho AL, Aires TS, Villasboas-Bisneto JC, Queirroz A, et al. Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil. Emerg Infect Dis. 2008;14(3):505–8. Epub 2008/03/08. PubMed Central PMCID: PMC2570821. doi: 10.3201/eid1403.07106418325275
8. Marotto PC, Nascimento CM, Eluf-Neto J, Marotto MS, Andrade L, Sztajnbok J, et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis. 1999;29(6):1561–3. Epub 1999/12/10. doi: 10.1086/31350110585813
9. McBride AJ, Athanazio DA, Reis MG, Ko AI, Leptospirosis. Current opinion in infectious diseases. 2005;18(5):376–86. 16148523
10. Vieira SR, Brauner JS, Leptospirosis as a cause of acute respiratory failure: clinical features and outcome in 35 critical care patients. Braz J Infect Dis. 2002;6(3):135–9. Epub 2002/07/30. 12144750
11. Goncalves-de-Albuquerque CF, Burth P, Silva AR, Younes-Ibrahim M, Castro-Faria-Neto HC, Castro-Faria MV, Leptospira and inflammation. Mediators of inflammation. 2012;2012:317950. PubMed Central PMCID: PMC3485547. doi: 10.1155/2012/31795023132959
12. Faine S, Adler B., Bolin C., Perolat P., Leptospira and Leptospirosis. 2nd ed.Melbourne, Australia: MediSci; 1999.
13. Dolinay T, Kim YS, Howrylak J, Hunninghake GM, An CH, Fredenburgh L, et al. Inflammasome-regulated cytokines are critical mediators of acute lung injury. American journal of respiratory and critical care medicine. 2012;185(11):1225–34. PubMed Central PMCID: PMC3373064. doi: 10.1164/rccm.201201-0003OC22461369
14. Hotchkiss RS, Monneret G, Payen D, Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nature reviews Immunology. 2013;13(12):862–74. PubMed Central PMCID: PMC4077177. doi: 10.1038/nri355224232462
15. Fialho RN, Martins L, Pinheiro JP, Bettencourt BF, Couto AR, Santos MR, et al. Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis. Hum Immunol. 2009;70(11):915–20. doi: 10.1016/j.humimm.2009.08.00719683555
16. Cedola M, Chiani Y, Pretre G, Alberdi L, Vanasco B, Gomez RM, Association of Toll-like receptor 2 Arg753Gln and Toll-like receptor 1 Ile602Ser single-nucleotide polymorphisms with leptospirosis in an Argentine population. Acta Trop. 2015;146:73–80. doi: 10.1016/j.actatropica.2015.03.00725784560
17. Ko AI, Galvao Reis M, Ribeiro Dourado CM, Johnson WD, Jr.Riley LW, Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet. 1999;354(9181):820–5. Epub 1999/09/15. 10485724
18. Reis RB, Ribeiro GS, Felzemburgh RD, Santana FS, Mohr S, Melendez AX, et al. Impact of environment and social gradient on Leptospira infection in urban slums. PLoS neglected tropical diseases. 2008;2(4):e228. PubMed Central PMCID: PMC2292260. doi: 10.1371/journal.pntd.000022818431445
19. Barocchi MA, Ko AI, Ferrer SR, Faria MT, Reis MG, Riley LW, Identification of new repetitive element in Leptospira interrogans serovar copenhageni and its application to PCR-based differentiation of Leptospira serogroups. J Clin Microbiol. 2001;39(1):191–5. PubMed Central PMCID: PMC87700. doi: 10.1128/JCM.39.1.191-195.200111136769
20. Panaphut T, Domrongkitchaiporn S, Thinkamrop B, Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis. 2002;6(1):52–9. Epub 2002/06/05. 12044303
21. Tajiki H, Salomao R, Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin Infect Dis. 1996;23(5):1177–8. 8922824
22. Kyriakidis I, Samara P, Papa A, Serum TNF-alpha, sTNFR1, IL-6, IL-8 and IL-10 levels in Weil's syndrome. Cytokine. 2011;54(2):117–20. Epub 2011/02/15. doi: 10.1016/j.cyto.2011.01.01421316985
23. Reis EA, Hagan JE, Ribeiro GS, Teixeira-Carvalho A, Martins-Filho OA, Montgomery RR, et al. Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis. PLoS neglected tropical diseases. 2013;7(9):e2457. PubMed Central PMCID: PMC3777885. doi: 10.1371/journal.pntd.000245724069500
24. Mikulski M, Boisier P, Lacassin F, Soupe-Gilbert ME, Mauron C, Bruyere-Ostells L, et al. Severity markers in severe leptospirosis: a cohort study. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. 2014.
25. Kobayashi Y, Clinical observation and treatment of leptospirosis. Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy. 2001;7(2):59–68.
26. Craig SB, Graham GC, Burns MA, Dohnt MF, Smythe LD, McKay DB, Haematological and clinical-chemistry markers in patients presenting with leptospirosis: a comparison of the findings from uncomplicated cases with those seen in the severe disease. Annals of tropical medicine and parasitology. 2009;103(4):333–41. doi: 10.1179/136485909X43505819508751
27. Abraham E, Carmody A, Shenkar R, Arcaroli J, Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. American journal of physiology Lung cellular and molecular physiology. 2000;279(6):L1137–45. 11076804
28. Goeijenbier M, Gasem MH, Meijers JC, Hartskeerl RA, Ahmed A, Goris MG, et al. Markers of endothelial cell activation and immune activation are increased in patients with severe leptospirosis and associated with disease severity. The Journal of infection. 2015.
29. Abdulkader RC, Daher EF, Camargo ED, Spinosa C, da Silva MV, Leptospirosis severity may be associated with the intensity of humoral immune response. Revista do Instituto de Medicina Tropical de Sao Paulo. 2002;44(2):79–83. 12048544
30. Haake DA, Mazel MK, McCoy AM, Milward F, Chao G, Matsunaga J, et al. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infection and immunity. 1999;67(12):6572–82. PubMed Central PMCID: PMC97069. 10569777
31. Adler B, Faine S, Host immunological mechanisms in the resistance of mice to leptospiral infections. Infection and immunity. 1977;17(1):67–72. PubMed Central PMCID: PMC421082. 885617
32. Chassin C, Picardeau M, Goujon JM, Bourhy P, Quellard N, Darche S, et al. TLR4- and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans. J Immunol. 2009;183(4):2669–77. doi: 10.4049/jimmunol.090050619635914
33. Huang da W, Sherman BT, Lempicki RA, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols. 2009;4(1):44–57. doi: 10.1038/nprot.2008.21119131956
34. Huang da W, Sherman BT, Lempicki RA, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research. 2009;37(1):1–13. PubMed Central PMCID: PMC2615629. doi: 10.1093/nar/gkn92319033363
35. Parnell GP, Tang BM, Nalos M, Armstrong NJ, Huang SJ, Booth DR, et al. Identifying key regulatory genes in the whole blood of septic patients to monitor underlying immune dysfunctions. Shock. 2013;40(3):166–74. doi: 10.1097/SHK.0b013e31829ee60423807251
36. Maecker HT, McCoy JP, Nussenblatt R, Standardizing immunophenotyping for the Human Immunology Project. Nature reviews Immunology. 2012;12(3):191–200. PubMed Central PMCID: PMC3409649. doi: 10.1038/nri315822343568
37. Annika Linde GHL, Javier Abello and Tonatiuh Melgarejo. Clinical Relevance of Cathelicidin in Infectious Disease. Journal of Clinical Cell Immunology. 2013;S13:003.
38. Molnarfi N, Benkhoucha M, Funakoshi H, Nakamura T, Lalive PH, Hepatocyte growth factor: A regulator of inflammation and autoimmunity. Autoimmunity reviews. 2015;14(4):293–303. doi: 10.1016/j.autrev.2014.11.01325476732
39. Kornblit B, Hellemann D, Munthe-Fog L, Bonde J, Strom JJ, Madsen HO, et al. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts. Immunobiology. 2013;218(10):1227–34. doi: 10.1016/j.imbio.2013.04.01023706599
40. Eigenbrod T, Pelka K, Latz E, Kreikemeyer B, Dalpke AH, TLR8 Senses Bacterial RNA in Human Monocytes and Plays a Nonredundant Role for Recognition of Streptococcus pyogenes. J Immunol. 2015;195(3):1092–9. doi: 10.4049/jimmunol.140317326101323
41. Kruger A, Oldenburg M, Chebrolu C, Beisser D, Kolter J, Sigmund AM, et al. Human TLR8 senses UR/URR motifs in bacterial and mitochondrial RNA. EMBO Rep. 2015;16(12):1656–63. PubMed Central PMCID: PMC4687425. doi: 10.15252/embr.20154086126545385
42. Eberle F, Sirin M, Binder M, Dalpke AH, Bacterial RNA is recognized by different sets of immunoreceptors. Eur J Immunol. 2009;39(9):2537–47. doi: 10.1002/eji.20083897819662634
43. Mancuso G, Gambuzza M, Midiri A, Biondo C, Papasergi S, Akira S, et al. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat Immunol. 2009;10(6):587–94. doi: 10.1038/ni.173319430477
44. Sambri V, Marangoni A, Giacani L, Gennaro R, Murgia R, Cevenini R, et al. Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. J Antimicrob Chemother. 2002;50(6):895–902. 12461010
45. Isogai E, M. H Isogai H, Matsuo K, Watarai S, Miura H, et al. Antimicrobial and Lipopolysaccharide-Binding Activities of C-terminal Domain of Human CAP18 Peptides to Genus Leptospira. The Journal of Applied Research. 2004;4(1):180–5.
46. Tajiki MH, Satie Nakama A, Salomao R, The ratio of plasma levels of IL-10/TNF-alpha and its relationship to disease severity and survival in patients with leptospirosis. Braz J Infect Dis. 1997;1(3):138–41. 11105129
47. Stromstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M, Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother. 2009;53(2):593–602. PubMed Central PMCID: PMC2630634. doi: 10.1128/AAC.00477-0819029324
48. Gronberg A, Mahlapuu M, Stahle M, Whately-Smith C, Rollman O, Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial. Wound Repair Regen. 2014;22(5):613–21. doi: 10.1111/wrr.1221125041740
49. Intratumoral Injections of LL37 for Melanoma https://clinicaltrials.gov/ct2/show/NCT02225366: M.D. Anderson Cancer Center; 2016 [18JUL2016]. Available from: https://clinicaltrials.gov/ct2/show/NCT02225366.
50. Prakash M, Bodas M, Prakash D, Nawani N, Khetmalas M, Mandal A, et al. Diverse pathological implications of YKL-40: answers may lie in 'outside-in' signaling. Cellular signalling. 2013;25(7):1567–73. doi: 10.1016/j.cellsig.2013.03.01623562456
51. Novick D, Kim S, Kaplanski G, Dinarello CA, Interleukin-18, more than a Th1 cytokine. Seminars in immunology. 2013;25(6):439–48. doi: 10.1016/j.smim.2013.10.01424275602
52. Grobmyer SR, Lin E, Lowry SF, Rivadeneira DE, Potter S, Barie PS, et al. Elevation of IL-18 in human sepsis. Journal of clinical immunology. 2000;20(3):212–5. 10941829
53. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL, Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. Journal of the American Society of Nephrology: JASN. 2005;16(10):3046–52. doi: 10.1681/ASN.200503023616148039
54. Adler B, Faine S, The antibodies involved in the human immune response to leptospiral infection. Journal of medical microbiology. 1978;11(4):387–400. doi: 10.1099/00222615-11-4-387722781
55. Jost BH, Adler B, Vinh T, Faine S, A monoclonal antibody reacting with a determinant on leptospiral lipopolysaccharide protects guinea pigs against leptospirosis. Journal of medical microbiology. 1986;22(3):269–75. doi: 10.1099/00222615-22-3-2692430103
56. Srikram A, Zhang K, Bartpho T, Lo M, Hoke DE, Sermswan RW, et al. Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant. J Infect Dis. 2011;203(6):870–9. PubMed Central PMCID: PMC3071135. doi: 10.1093/infdis/jiq12721220775
57. Maneewatch S, Sakolvaree Y, Saengjaruk P, Srimanote P, Tapchaisri P, Tongtawe P, et al. Monoclonal antibodies to LipL32 protect against heterologous Leptospira spp. challenge. Hybridoma (Larchmt). 2008;27(6):453–65.
58. Esteves LM, Bulhoes SM, Branco CC, Mota FM, Paiva C, Cabral R, et al. Human leptospirosis: seroreactivity and genetic susceptibility in the population of Sao Miguel Island (Azores, Portugal). PLoS One. 2014;9(9):e108534. PubMed Central PMCID: PMC4177921. doi: 10.1371/journal.pone.010853425255143
59. Lingappa J, Kuffner T, Tappero J, Whitworth W, Mize A, Kaiser R, et al. HLA-DQ6 and ingestion of contaminated water: possible gene-environment interaction in an outbreak of Leptospirosis. Genes Immun. 2004;5(3):197–202. doi: 10.1038/sj.gene.636405815014429
60. Stoddard RA, Gee JE, Wilkins PP, McCaustland K, Hoffmaster AR, Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene. Diagnostic microbiology and infectious disease. 2009;64(3):247–55. doi: 10.1016/j.diagmicrobio.2009.03.01419395218
61. Smythe LD, Smith IL, Smith GA, Dohnt MF, Symonds ML, Barnett LJ, et al. A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp. BMC infectious diseases. 2002;2:13. PubMed Central PMCID: PMC117785. doi: 10.1186/1471-2334-2-1312100734
62. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG, Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81. PubMed Central PMCID: PMC2700030. doi: 10.1016/j.jbi.2008.08.01018929686
63. Hagan JE, Moraga P, Costa F, Capian N, Ribeiro GS, Wunder EA, Jr.et al. Spatiotemporal Determinants of Urban Leptospirosis Transmission: Four-Year Prospective Cohort Study of Slum Residents in Brazil. PLoS neglected tropical diseases. 2016;10(1):e0004275. PubMed Central PMCID: PMC4714915. doi: 10.1371/journal.pntd.000427526771379
64. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic acids research. 2015.
65. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets—update. Nucleic acids research. 2013;41(Database issue):D991–5. PubMed Central PMCID: PMC3531084. doi: 10.1093/nar/gks119323193258
66. Tusher VG, Tibshirani R, Chu G, Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(9):5116–21. PubMed Central PMCID: PMC33173. doi: 10.1073/pnas.09106249811309499
67. Alter O, Brown PO, Botstein D, Singular value decomposition for genome-wide expression data processing and modeling. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(18):10101–6. PubMed Central PMCID: PMC27718. 10963673
68. Popper SJ, Shimizu C, Shike H, Kanegaye JT, Newburger JW, Sundel RP, et al. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome biology. 2007;8(12):R261. PubMed Central PMCID: PMC2246263. doi: 10.1186/gb-2007-8-12-r26118067656
69. Breuer K, Foroushani AK, Laird MR, Chen C, Sribnaia A, Lo R, et al. InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation. Nucleic acids research. 2013;41(Database issue):D1228–33. PubMed Central PMCID: PMC3531080. doi: 10.1093/nar/gks114723180781
70. Qian F, Goel G, Meng H, Wang X, You F, Devine L, et al. Systems immunology reveals markers of susceptibility to West Nile virus infection. Clinical and vaccine immunology: CVI. 2015;22(1):6–16. PubMed Central PMCID: PMC4278927. doi: 10.1128/CVI.00508-1425355795
71. Bruggner RV, Bodenmiller B, Dill DL, Tibshirani RJ, Nolan GP, Automated identification of stratifying signatures in cellular subpopulations. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(26):E2770–7. PubMed Central PMCID: PMC4084463. doi: 10.1073/pnas.140879211124979804
72. Silva EF, Santos CS, Athanazio DA, Seyffert N, Seixas FK, Cerqueira GM, et al. Characterization of virulence of Leptospira isolates in a hamster model. Vaccine. 2008;26(31):3892–6. PubMed Central PMCID: PMC2519131. doi: 10.1016/j.vaccine.2008.04.08518547690
73. Wunder EA, Jr.Figueira CP, Santos GR, Lourdault K, Matthias MA, Vinetz JM, et al. Real-Time PCR Reveals Rapid Dissemination of Leptospira interrogans after Intraperitoneal and Conjunctival Inoculation of Hamsters. Infection and immunity. 2016;84(7):2105–15. PubMed Central PMCID: PMC4936353. doi: 10.1128/IAI.00094-1627141082